---
title: "The height-increasing company Yingruike exposed by 315 has no patents"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279157405.md"
description: "The 315 Gala exposed a height-increasing scam. Yingruike Health Management Co., Ltd. was established in 2024 with a registered capital of 500,000 yuan, and the legal representative is Pan Moumou. The company currently has no patents and claims to help children grow taller without injections or medication. Pan Moumou is also associated with 15 other companies"
datetime: "2026-03-15T13:07:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279157405.md)
  - [en](https://longbridge.com/en/news/279157405.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279157405.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/279157405.md) | [繁體中文](https://longbridge.com/zh-HK/news/279157405.md)


# The height-increasing company Yingruike exposed by 315 has no patents

This year's 315 Gala exposed three chain height-increasing scams. According to the Qichacha APP, the company named, Suzhou Yingruike Health Management Co., Ltd., was established in September 2024 with a registered capital of 500,000 yuan, and is legally represented and effectively controlled by Pan Moumou. It is worth mentioning that the company currently has no patents. The official website claims that Yingruike can help children grow taller without injections or medication. Qichacha shows that Pan Moumou is associated with 15 companies, including Suzhou Yingdake Health Management Co., Ltd., Suzhou Yingxiaoke Health Management Co., Ltd., and Hefei Yingruike Health Management Co., Ltd. (Securities Times · e Company)

### Related Stocks

- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)

## Related News & Research

- [XORTX Confirms Effective Date of Share Consolidation | XRTX Stock News](https://longbridge.com/en/news/281404463.md)
- [Gilead Sciences Inc Stock (GILD) Moved Up by 3.62% on Mar 31: A Full Analysis](https://longbridge.com/en/news/281203982.md)
- [Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst⢠(bumetanide nasal spray)](https://longbridge.com/en/news/281570860.md)
- [Telehealth firm WeightWatchers' CEO departs company](https://longbridge.com/en/news/281657028.md)
- [Wuxi Lead Intelligent Equipment FY net profit amounted to RMB1,559.8 million](https://longbridge.com/en/news/281053550.md)